Telomeric repeat factor 1 protein levels correlates with telomere length in colorectal cancer Los niveles proteicos del factor de repetición telomérico 1 se correlacionan con la longitud del telómero en el cáncer colorrectal

Autor: Cristina Valls-Bautista, Carme Piñol-Felis, Josep M. Reñé-Espinet, Juan Buenestado-García, Joan Viñas-Salas

Publikováno v: Revista Espanola de Enfermedades Digestivas, Vol 104, Iss 10, Pp 530-536 (2012)

Background: colorectal cancer is the third cancer cause of death in Spain. It is important to investigate new tumoral markers for early diagnosis, disease monitoring and prevention strategies. Telomeres protect the chromosome from degradation by nucl

Externí odkaz: https://doaj.org/article/7203a49b5d76481392f23d6476bb1026

Telomerase Activity is a Prognostic Factor for Recurrence and Survival in Rectal Cancer

Autor: Cristina Valls Bautista, Josep Maria Reñé Espinet, Juan Buenestado García, Joan Viñas Salas, Carme Piñol Felis

Publikováno v: Diseases of the Colon & Rectum. 50:611-620

This study was designed to determine whether telomerase activity measured in samples of tumoral tissue, transitional mucosa, and normal mucosa from patients with sporadic colorectal cancer is a prognostic factor for recurrence and overall survival.Te

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3577c1ece5b9259c2eba3dcb55dad05f
https://doi.org/10.1007/s10350-006-0820-y

In colon cancer, normal colon tissue and blood cells have altered telomere lengths

Autor: Cristina, Valls-Bautista, Carme, Piñol-Felis, Josep M, Reñé-Espinet, Juan, Buenestado-García, Joan, Viñas-Salas

Publikováno v: Journal of surgical oncology. 111(7)

Telomere length (TL) shortened occurs in colorectal carcinogenetic process. Our objective is to determine if it is only a local fact or there are alterations in normal colon cells and in other body cells.TL of tumoral and normal mucosa and leukocytes

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::c36f73cd7a7fb4492cc73b5a6e446d6c
https://pubmed.ncbi.nlm.nih.gov/25873347

[Early virologic response value as predictive factor of sustained virologic response to treatment with interferon alpha-2b plus ribavirin in chronic hepatitis C patients with or without HIV coinfection]

Autor: Juan, Buenestado-García, Manuel, Rubio-Rivas, Josep Maria, Reñé-Espinet, Carmen, Piñol-Felis, Ramón, Egido-García, Manuel, Rubio-Caballero

Publikováno v: Medicina clinica. 127(15)

The most effective currently available therapy for chronic hepatitis C virus infection is the combination of interferon alpha-2b plus ribavirin both, in patients with human immunodeficiency virus (HIV) coinfection and in patients without coinfection.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::387001eb5310f4b68cc0261d7ed58599
https://pubmed.ncbi.nlm.nih.gov/17145015

Telomeric repeat factor 1 protein levels correlates with telomere length in colorectal cancer

Autor: Carme Piñol-Felis, Cristina Valls-Bautista, Josep M. Reñé-Espinet, Juan Buenestado-García, Joan Viñas-Salas

Publikováno v: Scopus-Elsevier
Revista Española de Enfermedades Digestivas v.104 n.10 2012
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Repositorio Abierto de la UdL
Universitad de Lleida
ResearcherID
Europe PubMed Central
Recercat. Dipósit de la Recerca de Catalunya

Background: colorectal cancer is the third cancer cause of death in Spain. It is important to investigate new tumoral markers for early diagnosis, disease monitoring and prevention strategies. Telomeres protect the chromosome from degradation by nucl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c1d977e2da063b4e881aadd4a3a850d
http://www.scopus.com/inward/record.url?eid=2-s2.0-84871558938&partnerID=MN8TOARS